Corrigenda: Residual enhancing disease after surgery for glioblastoma: evaluation of practice in the United Kingdom

Erratum to Ma et al. Residual enhancing disease after surgery for glioblastoma: evaluation of practice in the United Kingdom. Neurooncol Pract (first published online 27 September 2017 doi:10.1093/nop/npx023